What we can learn from open-label extensions of randomized clinical trials

被引：10

作者：

Cummings, JL ^{[1
]}

机构：

[1] Univ Calif Los Angeles, Reed Neurol Res Ctr, David Geffen Sch Med, Los Angeles, CA 90024 USA

来源：

ARCHIVES OF NEUROLOGY | 2006年 / 63卷 / 01期

关键词：

D O I：

10.1001/archneur.63.1.18

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：18 / 19

页数：2

共 10 条

[1] Management of patients with Alzheimer's disease plus cerebrovascular disease: 12-month treatment with galantamine [J].

Bullock, R ;

Erkinjuntti, T ;

Lilienfeld, S .

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2004, 17 (1-2) :29-34

[2] A 52-week study of the efficacy of rivastigmine in patients with mild to moderately severe Alzheimer's disease [J].

Farlow, M ;

Anand, R ;

Messina, J ;

Hartman, R ;

Veach, J .

EUROPEAN NEUROLOGY, 2000, 44 (04) :236-241

[3]

LEBER P, 1997, ALZHEIMER DIS ASS S5, V11, P10

[4] Long-term outcomes of galantamine treatment in patients with Alzheimer disease [J].

Lyketsos, CG ;

Reichman, WE ;

Kershaw, P ;

Zhu, Y .

AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2004, 12 (05) :473-482

[5] A 24-week open-label extension study of memantine in moderate to severe Alzheimer disease [J].

Reisberg, B ;

Doody, R ;

Stöffler, A ;

Schmitt, F ;

Ferris, S ;

Möbius, HJ .

ARCHIVES OF NEUROLOGY, 2006, 63 (01) :49-54

[6] Memantine in moderate-to-severe Alzheimer's disease [J].

Reisberg, B ;

Doody, R ;

Stoffler, A ;

Schmitt, F ;

Ferris, S ;

Mobius, HJ .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (14) :1333-1341

[7] Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: final analysis of a US multicentre open-label study [J].

Rogers, SL ;

Doody, RS ;

Pratt, RD ;

Ieni, JR .

EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2000, 10 (03) :195-203

[8] Relationship of disease severity to decline on specific cognitive and functional measures in Alzheimer disease [J].

Schmeidler, J ;

Mohs, RC ;

Aryan, M .

ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1998, 12 (03) :146-151

[9]

STERN RG, 1994, AM J PSYCHIAT, V151, P390

[10] Clinical trial designs for demonstrating disease-course-altering effects in dementia [J].

Whitehouse, PJ ;

Kittner, B ;

Roessner, M ;

Rossor, M ;

Sano, M ;

Thal, G ;

Winblad, B .

ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1998, 12 (04) :281-294

← 1 →